Interestingly, we observed the lowest OS in group IV*, even though it had high levels of CD8A, whereas Group III* had the most favorable outcomes for colon cancer with higher CD8A expression in the absence of IDO1 expression (P = 0.032) (Figure 4C). This evidence concerns the gene IDO1 and malignant colon neoplasm.